Su principal diferencia es el tipo de receptores que activan en el cuerpo para controlar el apetito y el metabolismo
The phase 2 trial used the same starting doses across all participants regardless of body weight, and the GI side effect profile was similar across weight categories
Semaglutides effects extend to decreasing the risk of heart failure, heart attacks, and other major cardiovascular problems by also reducing the inflammation that can damage blood vessels
Yes, Retatrutide promotes fat burning through its Glucagon receptor activity, which encourages the body to break down stored fat for energy
Based on this, the researchers estimated that semaglutide could reduce the obesity prevalence by 46.1% in the U.S., leading to 43 million fewer people with obesity
It could lead to better patient outcomes